Sarepta Therapeutics Inc. (srpt 1.5 11/15/24)
13F holders, Q3 2024 (September 30)2holders
0new positions
0sold out
$1.71avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.5 11/15/24) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holders were Boothbay Fund Management, LLC ($7.5M) and Fox Hill Wealth Management ($41K).
- Company
- Sarepta Therapeutics Inc. (srpt 1.5 11/15/24)
- CUSIP
- 803607AB6
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Boothbay Fund Management, LLC | 0.25% | No change | 4,389,000 | $7.5M |
| Fox Hill Wealth Management | 0.02% | No change | 24,000 | $41K |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.5 11/15/24)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.5 11/15/24) the manager owns.